Your browser doesn't support javascript.
loading
Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial.
Nilsson, K; Klevebro, F; Sunde, B; Rouvelas, I; Lindblad, M; Szabo, E; Halldestam, I; Smedh, U; Wallner, B; Johansson, J; Johnsen, G; Aahlin, E K; Johannessen, H-O; Alexandersson von Döbeln, G; Hjortland, G O; Wang, N; Shang, Y; Borg, D; Quaas, A; Bartella, I; Bruns, C; Schröder, W; Nilsson, M.
Afiliação
  • Nilsson K; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm.
  • Klevebro F; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm.
  • Sunde B; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm.
  • Rouvelas I; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm.
  • Lindblad M; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm.
  • Szabo E; Department of Surgery, Faculty of Medicine and Health, Örebro University Hospital, Örebro.
  • Halldestam I; University Hospital of Linköping, Linköping.
  • Smedh U; Department of Surgery, Sahlgrenska University Hospital, Gothenburg.
  • Wallner B; Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå.
  • Johansson J; Department of Surgery, Skåne University Hospital, Lund, Sweden.
  • Johnsen G; Department of Gastrointestinal Surgery, St. Olav's Hospital, Trondheim University Hospital, Trondheim.
  • Aahlin EK; Department of GI and HPB Surgery, University Hospital of Northern Norway, Tromsø.
  • Johannessen HO; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway.
  • Alexandersson von Döbeln G; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm; Medical Unit of Head, Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Hjortland GO; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Wang N; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm.
  • Shang Y; Department of Medicine Huddinge, Karolinska Institutet, Stockholm.
  • Borg D; Department of Oncology, Skåne University Hospital, Lund, Sweden.
  • Quaas A; Institute of Pathology, University of Cologne, Cologne.
  • Bartella I; Department of General, Visceral, Cancer and Transplantation Surgery, University Hospital of Cologne, Cologne, Germany.
  • Bruns C; Department of General, Visceral, Cancer and Transplantation Surgery, University Hospital of Cologne, Cologne, Germany.
  • Schröder W; Department of General, Visceral, Cancer and Transplantation Surgery, University Hospital of Cologne, Cologne, Germany.
  • Nilsson M; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm. Electronic address: magnus.nilsson@ki.se.
Ann Oncol ; 34(11): 1015-1024, 2023 11.
Article em En | MEDLINE | ID: mdl-37657554
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_digestive_diseases / 6_esophagus_cancer Assunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_digestive_diseases / 6_esophagus_cancer Assunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article